Intravenous Infusions (XGHA:IIL) Median PS Value : GHS0.00 (As of Mar. 29, 2025)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Intravenous Infusions's Revenue per Share for the trailing twelve months (TTM) ended in . 20 was GHS. Intravenous Infusions's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is GHS0.00.

As of today (2025-03-29), Intravenous Infusions's share price is GHS0.05. Intravenous Infusions's Median PS Value is GHS0.00. Therefore, Intravenous Infusions's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Intravenous Infusions's Median PS Value or its related term are showing as below:

XGHA:IIL's Price-to-Median-PS-Value is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.86
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Intravenous Infusions Median PS Value Historical Data

The historical data trend for Intravenous Infusions's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Median PS Value Chart

Intravenous Infusions Annual Data

Trend

Median PS Value

Intravenous Infusions Semi-Annual Data

Median PS Value

Competitive Comparison of Intravenous Infusions's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Price-to-Median-PS-Value falls into.

Save Embed

;

Save Embed

;

Intravenous Infusions Median PS Value Calculation

Intravenous Infusions's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=		*
	=

10-Year Median PS Ratio is .
For company reported annually, GuruFocus uses latest annual data as the TTM data. Intravenous Infusions's Revenue per Share for the trailing twelve months (TTM) ended in . 20 was GHS.

Intravenous Infusions (XGHA:IIL) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Intravenous Infusions's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	0.05	/
	=

Intravenous Infusions Median PS Value Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.